UNH Fundamental Analysis & Score

UnitedHealth Group Incorporated Healthcare Healthcare Plans
$402.02
Quote dated October 16, 2026
55/100
Hold

What this score covers. It is a fixed screen of five reported ratios with no valuation input, so a company can score highly while its valuation risk remains elevated. The full report scores valuation separately, as one of nine scored sections. How the score is calculated

View Plans
Page generated: October 16, 2026 at 18:22 UTC

Key Financial Metrics

Market Cap
$360.85B
P/E Ratio (TTM)
25.9x
P/E Forward
17.3x
Revenue Growth
-0.4%
Gross Margin
20.0%
Net Margin
3.5%
Return on Equity
15.8%
Debt/Equity
0.70

Rule-Based Financial Screen Summary

UnitedHealth Group Incorporated (UNH) is a Healthcare company in the Healthcare Plans industry. It has a 55/100 Hold score on our five-factor fundamentals screen. Key strengths include Return on Equity (15.8%). Areas to watch: Revenue Growth (-0.4%). The score is a five-factor screen — revenue growth, gross margin, net margin, return on equity and debt-to-equity — each scored against fixed thresholds from a neutral starting point of 50 points. The full report scores nine sections, including moat, free cash flow, dilution and valuation, which this screen does not.

Revenue Growth: Weak Gross Margin: Average Net Margin: Thin Return on Equity: Good Debt/Equity: Elevated

This page score and the strengths and concerns above are produced by deterministic, rule-based calculations from the available third-party financial inputs documented below. AI does not choose the score, strengths, or concerns. Data and automated summaries can contain errors. This is not personalized investment advice. See our methodology and disclaimer.

How this page score was calculated

The calculation starts at 50 points and applies the five fixed adjustments shown below. Missing or invalid inputs contribute no adjustment. A finite provider-reported zero is treated as a measured value and evaluated against that input's displayed threshold. The pre-clamp result is 55; the published result is clamped to a minimum of 10 and maximum of 98, producing 55/100.

UNH score inputs and fixed adjustments
Input Displayed value Threshold applied Adjustment Data status
Revenue Growth -0.4% 0% or lower -5 Available
Gross Margin 20.0% 35% or lower +2 Available
Net Margin 3.5% > 0% to 10% +2 Available
Return on Equity 15.8% > 12% to 20% +6 Available
Debt/Equity 0.70 0.60 to < 1.00 +0 Available

Score bands

80 or higher: Strong Buy; 65–79: Buy; 50–64: Hold; below 50: Caution.

These are fixed names for score ranges. The score is not a success probability, recommendation, or forecast, and 80/100 does not mean an 80% chance of a gain.

Not included in this score

  • Peer results or relative peer ranking
  • Demand zones or liquidity
  • Technical momentum
  • News or market sentiment
  • DCF valuation or the downloadable report score

Sources, freshness, and limitations

This page was generated . The provider identifies the latest underlying financial period as September 30, 2026. The displayed market quote is dated October 16, 2026. Generation time is not the same as the date of the underlying filing or market observation.

Financial inputs may be delayed, restated, differently standardized by the data provider, or unavailable. Missing, invalid, or non-finite values receive no positive or negative adjustment rather than being estimated. A finite provider-reported zero is retained and evaluated against that metric's displayed threshold; it is not treated as missing. This can make a sparse-data score less informative. The screen does not capture every business, market, valuation, or portfolio risk, and investors can lose money.

What the full UNH report adds

The 55/100 on this page comes from a fixed screen of 5 ratios. The downloadable report is a separate analysis with its own score, built from 9 weighted sections.

This page: fixed screen

  • Revenue Growth
  • Gross Margin
  • Net Margin
  • Return on Equity
  • Debt/Equity

Each factor is scored against fixed thresholds from a starting point of 50 points. No factor prices the stock, so valuation is not part of the 55/100.

Full report: 9 scored sections

  1. Business Moat weight 15 of 100
  2. Revenue Growth Consistency weight 14 of 100
  3. Margin Quality weight 12 of 100
  4. Free Cash Flow Strength weight 12 of 100
  5. Balance Sheet Safety weight 12 of 100
  6. Returns on Capital weight 12 of 100
  7. Dilution vs Self-Funded Growth weight 8 of 100
  8. Valuation vs Growth weight 10 of 100
  9. Structural vs Cyclical Growth weight 5 of 100

When the inputs allow, the report also shows a fair-value estimate with its discounted cash flow (DCF) assumptions and a 3×3 sensitivity table, a confidence figure, and the data limitations that reduced that confidence. Its headline label can add a valuation-risk flag next to the fundamental-quality rating.

Open the UNH report page

Supplementary Metrics for UNH

5 data points drawn from analyst targets, consensus estimates, and ownership data. These are supplementary observations, not event predictions or causal explanations:

The current provider record reports earnings growth of 75.9%.
The provider-reported analyst mean target is $477.04 (+18.7% from the displayed price), based on 25 estimates. This is third-party opinion, not a StrongBuyAnalytics target.
The provider-reported third-party analyst consensus category is Buy; it is not a StrongBuyAnalytics recommendation.
The current provider record reports institutional ownership of 89.6%.
The current provider record reports a dividend yield of 2.28%.

UNH vs. ABBV, MRK, AMGN, JNJ

UNH is the only Healthcare Plans company we cover, so the comparison uses the nearest Healthcare companies by market capitalisation instead.

Comparison context only: this peer set is selected statically from our covered companies using industry and company-size context. Peer data and peer selection do not change the UNH page score.

Ticker Price Market Cap P/E Rev Growth Net Margin ROE
UNH $402.02 $360.85B 25.9x -0.4% 3.5% 15.8%
ABBV $285.04 $503.69B 80.5x 10.2% 9.8% —
MRK $146.53 $361.50B 116.3x 5.1% 4.8% 7.0%
AMGN $432.70 $233.93B 26.9x 9.5% 23.0% 91.5%
JNJ $255.30 $615.25B 38.7x 5.9% 16.2% —

Risk Indicators for UNH

3 measurable indicators visible in UnitedHealth Group Incorporated's reported numbers. These are market and valuation risk metrics — not a comprehensive list of business risks, which would require qualitative analysis beyond this data:

Revenue Growth (-0.4%)
The provider-reported beta is 0.61. A beta below 1 reflects smaller historical price moves relative to the provider's benchmark; it does not cap future gains or losses.
The provider-reported short ratio is 3.1 days to cover. Short-interest data can be delayed and may reflect hedging or other strategies, so it does not establish investor intent or future direction.

UNH Balance Sheet & Cash Flow

UnitedHealth Group Incorporated's liquidity and cash generation as of the most recent filing — note the cash position of $28.55B against $74.33B of debt:

Total Cash
$28.55B
Total Debt
$74.33B
Current Ratio
0.74
FCF Yield
7.3%
EBITDA
$28.90B
Operating Margin
5.8%

These are provider-normalized figures and may differ from the issuer's as-filed presentation, units, or latest amendment. Use source filings for verification.

UNH Valuation Snapshot

Trailing P/E
25.9x
Growth premium
Forward P/E
17.3x
Earnings growth expected
Price / Book
3.5x
Premium
PEG Ratio
1.04
Fairly valued
Analyst Target (Mean)
$477.04
Range: $380 – $529
Dividend Yield
2.28%
5Y avg: 1.54%
52-Week Price Range — UNH is trading at 71% of its range
$255.97 (52W Low) $461.62 (52W High)

Who Holds UNH? — Institutional 13F Filings

Institutional investment managers with >$100 M in qualifying assets must disclose their equity positions quarterly on SEC Form 13F — typically within 45 days of quarter-end. Search those filings below to see which hedge funds, mutual funds, and asset managers reported UNH as a holding, how many shares they held, and how positions changed quarter over quarter.

Search 13F Filings for UNH Free · no sign-in required · live SEC EDGAR data
What you see free
Which institutions reported UNH, share counts, reported values, and direct links to the SEC filing.
Research Pro adds
Full manager portfolios — every position a fund holds, quarter-over-quarter changes, and concentration weights.
Data limitation
13F reports covered long positions for the filing's stated reporting period, typically a quarter-end—not on its later submission date. Short positions, full derivatives, and current intent are not disclosed.

How to Interpret the UNH Fundamentals Score

UNH rates 55/100 on our five-factor fundamentals screen, which puts it in the "Hold" band. The band name describes a fixed range in this model; it is not a recommendation or prediction. The calculation above shows how each reported input affected the result.

55/100 · Hold band

UnitedHealth Group Incorporated clears some of our thresholds and misses others. On the positive side, return on equity (15.8%). Against that, revenue growth (-0.4%). A middling score means the fundamentals are genuinely ambiguous, not that we have hedged.

UNH Earnings & Revenue Outlook

UnitedHealth Group Incorporated reported revenue decline of -0.4% year over year, against a Healthcare Plans peer set where scale and pricing power vary widely. A shrinking top line is a direct drag on the score, and it raises the bar for everything else in the model.

Earnings grew 75.9% over the same period, outpacing revenue — a sign of operating leverage.

Track upcoming report dates on our earnings calendar.

UNH Fundamental Factors to Monitor

This is a review of reported fundamentals, not a price target or an estimate of future returns. These are the current figures that may be useful to monitor as new filings become available.

Mixed current reading: Revenue decline of 0.4% sits alongside revenue growth (-0.4%). Watch whether those reported inputs move across the disclosed thresholds.

Positive Fundamental Inputs for UNH

These are the UnitedHealth Group Incorporated figures that push the score up, taken straight from the most recent reported financials:

  • Return on Equity (15.8%)

Negative Fundamental Inputs & Risks for UNH

These are the figures working against UNH in the same model:

  • Revenue Growth (-0.4%)

Learn More About Stock Analysis

Free 14-Min Course
Instructor
StrongBuy Analytics
Fundamental Research Team
How to Read Your Research Report
14Min
15Chapters
FreeNo sign-up

See how the metrics on this UNH page — quality score, valuation, DCF scenarios, confidence labels, and data limitations — are organized in the downloadable research report.

Generate My Free UNH Report

Guides to the specific measures used in this UNH analysis:

Fundamental Analysis Guide

How the financial statements behind this page fit together.

Understanding P/E Ratio

What UNH's 25.9x multiple does and does not tell you.

Return on Equity (ROE)

Why UNH's 15.8% return on equity matters for stock selection.

Stock Valuation Methods

How DCF, multiples and asset-based approaches value a company like UnitedHealth Group Incorporated.

DCF Assumptions and Limitations

What a discounted cash flow estimate for UNH depends on, and where it breaks down.

How to Read an AI Stock Report

What each section of a UNH report is for, and what it leaves out.

How to Read Earnings Reports

Where the UNH growth and margin figures on this page come from.

What Are Demand Zones?

The technical side we deliberately keep out of the UNH score.

Related Tools for UNH

Semiconductor Demand Zone Tracker UNH Live Chart UNH SEC Filing News Earnings Calendar Institutional Ownership Sector Scanner Average Down Calculator

UNH SEC Filing News

Latest SEC filings for UNH explained in plain English — insider buys/sells (Form 4), proposed sales (Form 144), material events (8-K), and quarterly & annual reports.

Loading recent SEC filings…
View all UNH SEC Filing News →

Frequently Asked Questions about UNH

Support and resistance are technical levels, so they are not part of the fundamentals score. Our demand zones page tracks semiconductor stocks; coverage does not extend to every ticker. Use the chart tool to identify price levels for UNH manually.

This UNH analysis is for educational and informational purposes only and does not constitute financial advice. Figures come from third-party feeds and can be delayed, standardized, incomplete, or inaccurate; verify material facts in primary filings and identified sources. Past performance does not guarantee future results. Read our full disclaimer.